In-vitro susceptibility of Borrelia burgdorferi and Borrelia hermsii to ten antimicrobial agents

Journal of Chemotherapy
V SambriM La Placa

Abstract

The in-vitro activity of ten antimicrobial agents against four strains of Borrelia burgdorferi originating both in the United States and Europe and against one isolate of B. hermsii was investigated. Ceftriaxone, erythromycin and roxithromycin were the most active drugs against both Borrelia species studied, with minimum bactericidal concentrations ranging from 0.015 micrograms/ml to 0.125 micrograms/ml.

References

Feb 1, 1990·The Journal of Antimicrobial Chemotherapy·B Cryan, D J Wright
Dec 1, 1984·Journal of Clinical Microbiology·R C JohnsonC Kodner

❮ Previous
Next ❯

Citations

Jul 1, 1994·Antimicrobial Agents and Chemotherapy·K D MoodyS W Barthold

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.